Search News Archives
Conferences | Events
New DMSO-Resistant 1536 Well Storage Plate
New 1536 well compound storage plate made of transparent cycloolefin at the Society conference exhibition
Greiner Bio-One, a leading technology partner for the diagnostic and pharmaceutical industry, has introduced new 1536 well compound storage plate made of transparent cycloolefin at the 'Society for Laboratory Automation and Screening' (SLAS) conference exhibition in San Diego, CA.
The excellent optical, chemical and physical properties of cycloolefin microplates make them extremely popular in highly automated research. The new 1536 well microplate from Greiner Bio-One is particularly suitable for storing active ingredients.
In response to the large demand for microplates made of the new material cycloolefin, Greiner Bio-One is now expanding its product portfolio of high-format microplates with a solid-base transparent 1536 well version.
Cycloolefin microplates are ideal for storing samples due to having a low water vapour permeability and resistance to polar solvents such as dimethyl sulfoxide (DMSO). Glass-like optical properties and a high level of transparency also enable use of the microplates for biochemical testing.
The footprint of the new 1536 well compound storage plate conforms to the recommendation of the American National Standards Institute (ANSI 1-2004).
The microplate top is absent of alphanumerical coding to render a smooth surface ideal for heat sealing and automated sealing techniques that use metal cover plates.
Unlike conventional 1536 well microplates made of polystyrene, the new microplate features a more conical well-top with a deeper volume, permitting even the smallest residues of sample material to be transferred.
About Greiner Bio-One
Greiner Bio-One GmbH BioScience Division Greiner Bio-One is specialised in the development, production and distribution of plastic laboratory products. The company is a technology partner for universities, research institutes and the diagnostic, pharmaceutical and biotechnology industries as well. With the BioScience division, Greiner Bio-One ranks among the leading providers of specialised products for the cultivation and analysis of cell and tissue cultures, as well as microplates for high-throughput screening, allowing industry and research most rapid and efficient drug screening. Additionally Greiner Bio-One develops innovative biochip technologies for genotyping.
Under the management of Georg Heftberger, Rainer Perneker and Heinz Schmid, the German headquarters of the BioScience division in Frickenhausen
(Baden-Württemberg) controls the whole research and development activities in the product ranges Cell Culture, High-Throughput Screening, Biochips and OEM.
Greiner Bio-One GmbH is a division of Greiner Bio-One International AG, based in Kremsmuenster (Austria). Today Greiner Bio-One International AG generates a turnover of 364 million euros. It has over 1,700 employees and operates globally with 24 subsidiaries and numerous distributors in more than 100 countries.